Outcomes after dose escalation of infliximab in Japanese patients with Crohn's disease

被引：0
|
作者：
Sako, M. [1 ]
Kawaguchi, T. [1 ]
Hirayama, A. [1 ]
Fukushi, G. [1 ]
Hayama, K. [1 ]
Fujiwara, T. [1 ]
Yoshimura, N. [1 ]
Takazoe, M. [1 ]
机构：
[1] Social Insurance Cent Hosp, Ctr Inflammatory Bowel Dis, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60517-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P397
引用
收藏
页码：S231 / S231
页数：1
相关论文
共 50 条
  • [1] Reactive dose escalation of infliximab in patients with Crohn's disease in TAILORIX leads to improved outcomes
    Dreesen, E.
    Laharie, D.
    Lambrecht, G.
    Bossuyt, P.
    Buisson, A.
    Filippi, J.
    Van Hootegem, P.
    D'Haens, G.
    Vermeire, S.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S396 - S397
  • [2] REACTIVE DOSE ESCALATION OF INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE IN TAILORIX LEADS TO IMPROVED OUTCOMES
    Dreesen, Erwin
    Laharie, David
    Lambrecht, Guy
    Bossuyt, Peter
    Buisson, Anthony
    Filippi, Jerome
    Van Hootegem, Philippe
    D'Haens, Geert R.
    Vermeire, Severine
    Gils, Ann
    GASTROENTEROLOGY, 2018, 154 (06) : S823 - S824
  • [3] Time of infliximab therapy initiation and dose escalation in Crohn's disease
    Mindy CW Lam
    Terry Lee
    Kenneth Atkinson
    Brian Bressler
    World Journal of Gastroenterology, 2014, (01) : 214 - 218
  • [4] Time of infliximab therapy initiation and dose escalation in Crohn's disease
    Lam, Mindy C. W.
    Lee, Terry
    Atkinson, Kenneth
    Bressler, Brian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (01) : 214 - 218
  • [5] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Nichols, Patrick
    Kozlicki, Miranda
    Fann, Jessica
    Zuckerman, Autumn
    Dalal, Robin
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S88 - S89
  • [6] RISANKIZUMAB DOSE ESCALATION IN PATIENTS WITH CROHN'S DISEASE
    Nichols, Patrick
    Kozlicki, Miranda
    Fann, Jessica
    Zuckerman, Autumn
    Dalal, Robin
    GASTROENTEROLOGY, 2024, 166 (03) : S123 - S123
  • [7] Risankizumab dose escalation in patients with Crohn's disease
    Zuckerman, Autumn
    Nichols, Patrick
    Fann, Jessica
    Kozlicki, Miranda
    Dalal, Robin
    CURRENT MEDICAL RESEARCH AND OPINION, 2024, 40 : S8 - S9
  • [8] Infliximab dose intensification in patients with Crohn's disease
    Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4 (11): : 588 - 589
  • [9] Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial
    Hisamatsu, Tadakazu
    Kunisaki, Reiko
    Nakamura, Shiro
    Tsujikawa, Tomoyuki
    Hirai, Fumihito
    Nakase, Hiroshi
    Watanabe, Kenji
    Yokoyama, Kaoru
    Nagahori, Masakazu
    Kanai, Takanori
    Naganuma, Makoto
    Michimae, Hirofumi
    Andoh, Akira
    Yamada, Akihiro
    Yokoyama, Tadashi
    Kamata, Noriko
    Tanaka, Shinji
    Suzuki, Yasuo
    Hibi, Toshifumi
    Watanabe, Mamoru
    INTESTINAL RESEARCH, 2018, 16 (03) : 494 - +
  • [10] Efficacy of Infliximab for Japanese Paediatric Crohn's Disease Patients
    Yokoyama, Yoko
    Fukunaga, Ken
    Miwa, Hiroto
    Matsumoto, Takayuki
    GASTROENTEROLOGY, 2012, 142 (05) : S376 - S376
12345